Correlation Between Lixte Biotechnology and TRACON Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Lixte Biotechnology and TRACON Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lixte Biotechnology and TRACON Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lixte Biotechnology Holdings and TRACON Pharmaceuticals, you can compare the effects of market volatilities on Lixte Biotechnology and TRACON Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lixte Biotechnology with a short position of TRACON Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lixte Biotechnology and TRACON Pharmaceuticals.

Diversification Opportunities for Lixte Biotechnology and TRACON Pharmaceuticals

0.0

Correlation Coefficient

Lixte Biotechnology  TRACON Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Lixte and TRACON is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Lixte Biotechnology Holdings and TRACON Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TRACON Pharmaceuticals and Lixte Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lixte Biotechnology Holdings are associated (or correlated) with TRACON Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TRACON Pharmaceuticals has no effect on the direction of Lixte Biotechnology i.e., Lixte Biotechnology and TRACON Pharmaceuticals go up and down completely randomly.

Pair Corralation between Lixte Biotechnology and TRACON Pharmaceuticals

If you would invest (100.00) in TRACON Pharmaceuticals on December 25, 2024 and sell it today you would earn a total of  100.00  from holding TRACON Pharmaceuticals or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Lixte Biotechnology Holdings  vs.  TRACON Pharmaceuticals

Lixte Biotechnology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lixte Biotechnology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

TRACON Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days TRACON Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, TRACON Pharmaceuticals is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Lixte Biotechnology and TRACON Pharmaceuticals

The main advantage of trading using opposite Lixte Biotechnology and TRACON Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lixte Biotechnology position performs unexpectedly, TRACON Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TRACON Pharmaceuticals will offset losses from the drop in TRACON Pharmaceuticals' long position.

The idea behind Lixte Biotechnology Holdings and TRACON Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.